TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -2 | -5 | -14 | -36 | -41 | -35 | -22 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/18/12 16:58 | 6/14/12 | SCLN | Sciclone Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Titus Gary | CA | O | SVP Fina | S.dm | -571 | 7.00 | 4 | -82 | -69 | 37 | D | 102 | 40 | 59 | 13 | 20 | 21 | 5 | -2 | -2 | -5 | -14 | -36 | -41 | -35 |
8/31/06 17:04 | 8/30/06 | NUVO | Nuvelo Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Titus Gary | CA | O | Chief Ac | S | -290 | 20.70 | 0 | -14 | -84 | 3 | D | ||||||||||||||
8/30/06 17:03 | 8/29/06 | NUVO | Nuvelo Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Titus Gary | CA | O | Chief Ac | S | -141 | 20.65 | 0 | -7 | -72 | 3 | D | ||||||||||||||
8/28/06 15:53 | 8/25/06 | NUVO | Nuvelo Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Titus Gary | CA | O | Chief Ac | S | -798 | 19.94 | 0 | -40 | -94 | 3 | D | ||||||||||||||
8/25/06 16:35 | 8/24/06 | NUVO | Nuvelo Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Titus Gary | CA | O | Chief Ac | S | -293 | 19.50 | 0 | -15 | -85 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |